Creator: Help Dementia Editorial Team
Published: 2026-04-19T06:19:51

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Mayo clinic sits at the center of this dementia and brain health question.

Recent headlines claiming that Mayo Clinic links the ketogenic diet to higher dementia risk misrepresent the actual medical research. The truth is quite different: Mayo Clinic researchers have published peer-reviewed studies indicating that a ketogenic dietary approach may actually *reduce* dementia risk and show promise for protecting cognitive health. This article will clarify what the science actually shows and why this misconception may be circulating. The confusion likely stems from broader dietary recommendations that have emphasized low-fat approaches for decades.

However, contemporary research from Mayo Clinic and other leading institutions suggests that the type of carbohydrates consumed—not dietary fat itself—may play a more significant role in dementia risk. In fact, Mayo Clinic research indicates that people whose diets are high in refined carbohydrates (pasta, bread, white potatoes, rice) have an 89% increased risk for dementia compared to those with lower carbohydrate intake, while ketogenic approaches show opposite effects. Understanding the actual evidence matters because dietary choices made today could influence cognitive health in the decades ahead. If you or a loved one is concerned about dementia risk, knowing what the research actually supports—rather than sensationalized headlines—is essential for making informed decisions.

What Does Mayo Clinic Actually Say About Ketogenic Diet and Dementia Risk?
The Mediterranean Ketogenic Diet Study and What It Shows
Why High-Carbohydrate Diets Show Greater Dementia Risk
How Ketogenic Approaches May Protect Brain Cells
Important Limitations and Individual Differences in Ketogenic Diets
The Historical Context: Mayo Clinic and Ketogenic Diet for Neurological Health
Future Research Directions and Practical Implications
Conclusion

What Does Mayo Clinic Actually Say About Ketogenic Diet and Dementia Risk?

mayo Clinic researchers have not published findings linking ketogenic diets to higher dementia risk. Instead, their published research points in the opposite direction. In studies published between 2024-2026 in Nature Communications Medicine, Mayo Clinic researchers examined how a modified Mediterranean ketogenic diet affects the body’s lipidome—the complete set of lipids (fats) in the blood and tissues. Their key finding: changes in plasma lipidome resulting from ketogenic dietary approaches showed inverse correlation with Alzheimer’s disease biomarkers, meaning the dietary changes associated with reduced markers of disease.

This distinction is important because biomarkers are measurable indicators of disease pathology that appear years before cognitive symptoms emerge. When a dietary approach correlates with *reduced* biomarkers, it suggests potential disease prevention rather than increased risk. The Mayo Clinic research team measured these biomarkers directly using advanced laboratory methods, not estimates or assumptions. For context, this represents a continuation of Mayo Clinic’s long-standing interest in dietary approaches to neurological health, dating back to 1921 when Dr. Russell Wilder introduced the ketogenic diet at the institution as a treatment for seizure disorders and other neurological conditions.

What Does Mayo Clinic Actually Say About Ketogenic Diet and Dementia Risk?

The Mediterranean Ketogenic Diet Study and What It Shows

The most recent Mayo Clinic research examined a specific dietary variant: the Mediterranean ketogenic diet, which combines principles of the Mediterranean diet (emphasis on olive oil, fish, vegetables, nuts) with ketogenic macronutrient ratios (high fat, moderate protein, very low carbohydrate). This isn’t the standard “keto” diet most people imagine; it’s a carefully designed version that retains some Mediterranean diet principles known to support brain health. In this study, researchers tracked changes in blood lipids and metabolites in people following the Mediterranean ketogenic approach. The results showed that specific lipid patterns shifted in ways that aligned with reduced amyloid and tau pathology—two hallmark features of Alzheimer’s disease.

Amyloid and tau accumulation occurs silently in the brain for years before causing memory problems or cognitive decline, making prevention at this early stage potentially crucial. One important limitation: these studies measured biomarkers in blood, which correlate with but are not identical to brain pathology. While the results are promising, long-term studies tracking whether people actually develop dementia at different rates would provide even stronger evidence. The research also raises questions about which populations benefit most and whether the diet’s effects are sustained long-term.

Why High-Carbohydrate Diets Show Greater Dementia Risk

If ketogenic diets don’t increase dementia risk, what about the diets most people consume? Mayo Clinic research indicates that high-carbohydrate diets—particularly those emphasizing refined carbohydrates—are associated with significantly elevated dementia risk. The striking finding: people consuming high-carbohydrate diets showed an 89% *increased* risk for dementia compared to those with lower carbohydrate consumption. This represents a substantial difference and stands in direct contrast to the premise of headlines suggesting ketogenic diets are problematic.

The mechanism appears related to how refined carbohydrates affect blood sugar and insulin levels. When the body regularly experiences sharp spikes and crashes in blood glucose (from eating white bread, pasta, sugary foods, and processed carbs), it may contribute to inflammation, oxidative stress, and dysfunction in how the brain clears waste products. This process happens gradually over years, making the connection between today’s dietary choices and dementia risk decades later difficult to perceive. The danger is that people following standard dietary guidelines heavy in refined carbohydrates may feel they’re making healthy choices while actually increasing their long-term cognitive risk.

Why High-Carbohydrate Diets Show Greater Dementia Risk

How Ketogenic Approaches May Protect Brain Cells

Understanding the potential mechanisms behind ketogenic dietary protection requires looking at brain metabolism. The brain typically runs primarily on glucose, but it can also efficiently use ketones—molecules produced when the body breaks down fat for energy during carbohydrate restriction. When the brain uses ketones, several beneficial processes appear to be activated. Ketones may enhance mitochondrial function (the energy-producing structures within cells), reduce inflammation, and improve the brain’s ability to clear accumulated proteins like amyloid and tau.

Compare two approaches: a high-carb diet that keeps blood glucose fluctuating creates an environment of frequent inflammatory spikes and oxidative stress in brain tissue, while a ketogenic approach maintains more stable energy availability and activates cellular cleanup mechanisms. This isn’t merely theoretical—researchers can measure markers of inflammation and oxidative stress in blood, and these markers improve with ketogenic approaches. However, there’s an important caveat: individual responses vary considerably based on genetics, existing health conditions, medications, and other lifestyle factors. Someone with certain metabolic conditions, kidney disease, or taking particular medications may not tolerate ketogenic diets well, meaning this approach isn’t universally appropriate despite its apparent benefits for dementia risk reduction.

Important Limitations and Individual Differences in Ketogenic Diets

While Mayo Clinic research shows promising connections between ketogenic approaches and reduced dementia biomarkers, several important limitations warrant emphasis. First, correlations between blood biomarkers and actual dementia development aren’t perfect—a person with improved biomarkers may still develop cognitive decline due to other factors like head trauma, stroke, or genetic mutations. Second, most research measuring cognitive outcomes is still short-term; we lack decades-long studies following people on ketogenic diets into their 70s and 80s to confirm that improved biomarkers translate to better real-world brain health. Third, ketogenic diets aren’t appropriate for everyone.

People with a history of kidney stones, certain metabolic disorders, or those taking medications that interact with ketogenic eating should consult healthcare providers before attempting this approach. Additionally, the transition period to ketogenic metabolism can produce unpleasant symptoms (“keto flu”) including fatigue, headaches, and brain fog that discourage adherence before potential benefits emerge. The Mediterranean ketogenic approach studied at Mayo Clinic requires more planning than standard eating, making sustainability challenging for many people. These practical and medical limitations mean that while ketogenic diets show promise for dementia prevention in research settings, translating this to real-world adherence and safety remains complex.

Important Limitations and Individual Differences in Ketogenic Diets

The Historical Context: Mayo Clinic and Ketogenic Diet for Neurological Health

Understanding how Mayo Clinic came to study ketogenic diets for brain protection requires historical perspective. In 1921, Dr. Russell Wilder introduced the ketogenic diet at Mayo Clinic specifically as a treatment for epilepsy and seizure disorders. This wasn’t accidental—Wilder observed that fasting seemed to reduce seizures in some patients and developed the ketogenic diet as a way to achieve fasting’s neurological benefits while still allowing food intake.

This 1921 innovation predates modern neuroscience by decades, yet it worked remarkably well for certain seizure types. This history matters because it established Mayo Clinic’s institutional knowledge about ketogenic metabolism and neurological health. When contemporary researchers at the same institution examine ketogenic approaches for dementia and Alzheimer’s disease, they’re building on a century of clinical observation and mechanistic understanding. The fact that ketogenic diets helped seizure disorders—now understood to involve abnormal neural firing and neuroinflammation—suggested they might address other neurological conditions affecting brain energy metabolism and inflammation. This historical foundation explains why Mayo Clinic, rather than a random laboratory, led recent research connecting ketogenic diets to improved dementia biomarkers.

Future Research Directions and Practical Implications

The next frontier in ketogenic diet and dementia research involves long-term studies tracking actual cognitive outcomes rather than just biomarkers. Several research groups, including Mayo Clinic, are now conducting multi-year studies following people on various dietary approaches to measure whether those with improved dementia biomarkers actually maintain better memory and thinking abilities as they age. These studies will answer the critical question: does improving biomarkers lead to measurable dementia prevention in real people? Additionally, researchers are investigating which specific populations benefit most from ketogenic approaches.

Age, genetic risk factors (such as carrying the APOE4 gene variant that increases Alzheimer’s risk), metabolic health status, and other variables may determine who experiences the greatest benefit. Understanding these factors will allow personalized recommendations rather than a one-size-fits-all dietary prescription. The ultimate goal is identifying specific dietary patterns that genuinely prevent or slow cognitive decline—and emerging evidence suggests ketogenic approaches deserve serious investigation, not dismissal based on misunderstood headlines.

Conclusion

The claim that Mayo Clinic links ketogenic diets to higher dementia risk fundamentally misrepresents current medical evidence. The actual research from Mayo Clinic and peer-reviewed journals indicates the opposite: ketogenic dietary approaches show associations with *reduced* dementia biomarkers and reduced cognitive risk, while high-carbohydrate diets—particularly those heavy in refined carbs—are linked to substantially elevated dementia risk. This distinction matters enormously for people making dietary choices today that will influence brain health decades from now.

If you’re concerned about dementia risk, consulting with a healthcare provider about dietary approaches suited to your individual health status makes sense. For some people, exploring Mediterranean ketogenic principles or reducing refined carbohydrate intake could offer cognitive benefits supported by Mayo Clinic research. For others, different dietary approaches may be more appropriate. The key is making informed decisions based on actual science rather than sensationalized headlines that reverse the research findings.